February 25, 2026 · Form 4 insider transaction
CAUSEY CHRISTOPHER sold 1,000 shares of United Therapeutics Corporation at $520.00 per share, a transaction worth $520.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.